Acute uveitis: A rare adverse effect of miltefosine in the treatment of post-kala-azar dermal leishmaniasis
Open Access
- 1 January 2021
- journal article
- research article
- Published by FapUNIFESP (SciELO) in Revista da Sociedade Brasileira de Medicina Tropical
- Vol. 54, e20200208
- https://doi.org/10.1590/0037-8682-0208-2020
Abstract
Post-kala-azar dermal leishmaniasis is a skin disorder occurring in 5-10% of visceral leishmaniasis patients after treatment with miltefosine,the first-line drug for this skin disorder. We reported a case of acute anterior uveitis,a rare adverse effect, experienced by a patient treated with miltefosine for post-kala-azar dermal leishmaniasis. This adverse effect developed after 15 days of miltefosine consumption, and the patient himself discontinued the treatment. The ophthalmic complication was completely resolved with antibiotics and steroid eye drops. After recovery from the ophthalmic complication, the patient was successfully treated with liposomal amphotericin B for the skin lesions.Keywords
This publication has 8 references indexed in Scilit:
- Adverse ocular events on miltefosine treatment for post-kala-azar dermal leishmaniasis in IndiaTropical Doctor, 2019
- Corneal complications following Post Kala-azar Dermal Leishmaniasis treatmentPLoS Neglected Tropical Diseases, 2018
- Inadequacy of 12-Week Miltefosine Treatment for Indian Post-Kala-Azar Dermal LeishmaniasisThe American Journal of Tropical Medicine and Hygiene, 2015
- Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasisJournal of Antimicrobial Chemotherapy, 2012
- Lysosomal Acidification MechanismsAnnual Review of Physiology, 2012
- Development of miltefosine as an oral treatment for leishmaniasisTransactions of the Royal Society of Tropical Medicine and Hygiene, 2006
- Post-kala-azar dermal leishmaniasisThe Lancet Infectious Diseases, 2003
- Oral Miltefosine for Indian Visceral LeishmaniasisThe New England Journal of Medicine, 2002